相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
Yoshiya Tanaka et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
Trained Immunity and Reactivity of Macrophages and Endothelial Cells
Charles Drummer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Tissue-specific endothelial cell heterogeneity contributes to unequal inflammatory responses
Hasitha Gunawardana et al.
SCIENTIFIC REPORTS (2021)
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib
Paqui G. Traves et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response
Maaria Palmroth et al.
FRONTIERS IN IMMUNOLOGY (2021)
Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model
Jatin Sharma et al.
SCIENTIFIC REPORTS (2021)
IFNγ, and to a Lesser Extent TNFα, Provokes a Sustained Endothelial Costimulatory Phenotype
Nicole M. Valenzuela
FRONTIERS IN IMMUNOLOGY (2021)
Endothelial Jak3 expression enhances pro-hematopoietic angiocrine function in mice
Jose Gabriel Barcia Duran et al.
COMMUNICATIONS BIOLOGY (2021)
Induction of CIITA by IFN-γ in macrophages involves STAT1 activation by JAK and JNK
Juan Tur et al.
IMMUNOBIOLOGY (2021)
TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells
Jerzy A. Woznicki et al.
CELL DEATH & DISEASE (2021)
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?
Christine Liu et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
Paola Di Benedetto et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Trained immunity in organ transplantation
Jordi Ochando et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy
Jianling Tao et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Endothelial heterogeneity across distinct vascular beds during homeostasis and inflammation
Ankit Jambusaria et al.
ELIFE (2020)
Complement-activated interferon-γ-primed human endothelium transpresents interleukin-15 to CD8+ T cells
Catherine B. Xie et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
Jin Ma et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Role of JAK inhibitors and immune cells in transplantation
Nicolas Sailliet et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2019)
Interferon target-gene expression and epigenomic signatures in health and disease
Franck J. Barrat et al.
NATURE IMMUNOLOGY (2019)
Clinical significance of Janus Kinase inhibitor selectivity
Ernest H. Choy
RHEUMATOLOGY (2019)
Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations
Iain B. McInnes et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection
Jordi Rovira et al.
TRANSPLANTATION (2018)
The molecular basis of JAK/STAT inhibition by SOCS1
Nicholas P. D. Liau et al.
NATURE COMMUNICATIONS (2018)
A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and type II IFN Responses
Agata Michalska et al.
FRONTIERS IN IMMUNOLOGY (2018)
Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis
Hui Zhang et al.
CIRCULATION (2018)
JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis
Jianling Tao et al.
KIDNEY INTERNATIONAL (2018)
Interferon stimulation creates chromatin marks and establishes transcriptional memory
Rui Kamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Review: The transcripts associated with organ allograft rejection
Philip F. Halloran et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1
Rebecca Liu et al.
JCI INSIGHT (2018)
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial
Stephan Busque et al.
TRANSPLANTATION DIRECT (2018)
Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
Yasuko Furumoto et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges?
Cody A. Moore et al.
HUMAN IMMUNOLOGY (2017)
Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System
Philip F. Halloran et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2017)
Antigen Presentation by vascular Cells
Jordan S. Pober et al.
FRONTIERS IN IMMUNOLOGY (2017)
Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology
Brian E. Sansbury et al.
CIRCULATION RESEARCH (2016)
Trained immunity: A program of innate immune memory in health and disease
Mihai G. Netea et al.
SCIENCE (2016)
Targeting JAK/STAT Signaling to Prevent Rejection After Kidney Transplantation: A Reappraisal
Carla C. Baan et al.
TRANSPLANTATION (2016)
Evaluation of the Effect of Tofacitinib Exposure on Outcomes in Kidney Transplant Patients
F. Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages
Alessandra Mancino et al.
GENES & DEVELOPMENT (2015)
Interferon-Gamma Increases Endothelial Permeability by Causing Activation of p38 MAP Kinase and Actin Cytoskeleton Alteration
Chin Theng Ng et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Causal analysis approaches in Ingenuity Pathway Analysis
Andreas Kraemer et al.
BIOINFORMATICS (2014)
Data Mining of Atherosclerotic Plaque Transcriptomes Predicts STAT1-Dependent Inflammatory Signal Integration in Vascular Disease
Krzysztof Sikorski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
Annkristin Heine et al.
BLOOD (2013)
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation
Purvesh Khatri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Differential Roles of JNK, ERK1/2, and p38 Mitogen-Activated Protein Kinases on Endothelial Cell Tissue Repair Functions in Response to Tumor Necrosis Factor-α
Nobuhiro Kanaji et al.
JOURNAL OF VASCULAR RESEARCH (2013)
Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year
F. Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
MKP-7, a negative regulator of JNK, regulates VCAM-1 expression through IRF-1
Irina Tsoy Nizamutdinova et al.
CELLULAR SIGNALLING (2012)
Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells
M. Nakano et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
IFN-γ-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cells
Beatrice Bolinger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
The IFN-γ-Dependent Suppressor of Cytokine Signaling 1 Promoter Activity Is Positively Regulated by IFN Regulatory Factor-1 and Sp1 but Repressed by Growth Factor Independence-1b and Kruppel-Like Factor-4, and It Is Dysregulated in Psoriatic Keratinocytes
Stefania Madonna et al.
JOURNAL OF IMMUNOLOGY (2010)
Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients
S. Busque et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During Atherosclerosis
Guadalupe Ortiz-Munoz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
STAT-1 decoy oligodeoxynucleotide inhibition of acute rejection in mouse heart transplants
Tomislav Stojanovic et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Twenty-year survivors of heart transplantation at Stanford University
T. Deuse et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators
Aksam J. Merched et al.
FASEB JOURNAL (2008)
Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-γ production by infiltrating T cells
Tai Yi et al.
TRANSPLANTATION (2008)
Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell-mediated injury in the heart
Nir Grabie et al.
CIRCULATION (2007)
PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection
Katsunori Tanaka et al.
JOURNAL OF IMMUNOLOGY (2007)
Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo
Stephen L. Shiao et al.
JOURNAL OF IMMUNOLOGY (2007)
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Klaus Ley et al.
NATURE REVIEWS IMMUNOLOGY (2007)
NK cells can trigger allograft vasculopathy: The role of hybrid resistance in solid organ allografts
S Uehara et al.
JOURNAL OF IMMUNOLOGY (2005)
Chemokine production and E-selectin expression in activated endothelial cells are inhibited by p38 MAPK (mitogen activated protein kinase) inhibitor RWJ 67657
J Westra et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity
B Liu et al.
NATURE IMMUNOLOGY (2004)
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
PS Changelian et al.
SCIENCE (2003)
JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of type II collagen, aggrecan core, and link protein transcription in articular chondrocytes - Association with a down-regulation of SOX9 expression
F Legendre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130
U Lehmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation
K Ramsauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Interferon-γ augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis
JH Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection
M Afrouzian et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
IFN-γ alters the pathology of graft rejection:: Protection from early necrosis
PF Halloran et al.
JOURNAL OF IMMUNOLOGY (2001)
Concomitant inhibition of janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts
F Behbod et al.
JOURNAL OF IMMUNOLOGY (2001)
IFN-γ regulation of class II transactivator promoter IV in macrophages and microglia:: Involvement of the suppressors of cytokine signaling-1 protein
GM O'Keefe et al.
JOURNAL OF IMMUNOLOGY (2001)
Induction of endothelial-leukocyte interaction by interferon-γ requires coactivation of nuclear factor-κB
R De Caterina et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis
PF Halloran et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
分享论文
